(PDF) Hedgehog Agonist Therapy Corrects Structural and

Hedgehog Agonist Therapy Corrects Structural and Cognitive Deficits in a Down Syndrome Mouse Model

Science Translational Medicine - United States

doi 10.1126/scitranslmed.3005983

Full Text

Abstract

Available in full text

Categories

Date

September 4, 2013

Authors

Publisher

American Association for the Advancement of Science (AAAS)

Related search

Reducing Histone Acetylation Rescues Cognitive Deficits in a Mouse Model of Fragile X Syndrome

Nature Communications

Molecular Biology

English

Specific Targeting of the GABA-A Receptor Α5 Subtype by a Selective Inverse Agonist Restores Cognitive Deficits in Down Syndrome Mice

Journal of Psychopharmacology

English

Long‐lasting Correction of in Vivo LTP and Cognitive Deficits of Mice Modelling Down Syndrome With an Α5‐selective GABAA Inverse Agonist

British Journal of Pharmacology

English

DYRK1A Inhibition and Cognitive Rescue in a Down Syndrome Mouse Model Are Induced by New Fluoro-Dandy Derivatives

Scientific Reports

Multidisciplinary

English

Lovastatin Corrects Excess Protein Synthesis and Prevents Epileptogenesis in a Mouse Model of Fragile X Syndrome

English

The Mouse Model of Down Syndrome Ts65Dn Presents Visual Deficits as Assessed by Pattern Visual Evoked Potentials

Investigative Ophthalmology and Visual Science

Molecular Neuroscience

Sensory Systems

English

Designer Receptors Enhance Memory in a Mouse Model of Down Syndrome

Journal of Neuroscience

English

Developmentally Altered Inhibition in Ts65Dn, a Mouse Model of Down Syndrome

Developmental Biology

Molecular Biology

English

Structural Deficits and Cognitive Impairment in Tuberculous Meningitis

BMC Infectious Diseases

Infectious Diseases

English